Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-15 · accession 0001209191-22-057740 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-17 | 2022-11-15 | TMCI | Owens Daniel E. | CHRO | M - OptEx | $7.03 | +6,250 | 16.9K | +58% | +$43.9K |
| D | 2022-11-17 | 2022-11-15 | TMCI | Owens Daniel E. | CHRO | S - Sale+OE | $20.38 | -6,250 | 10.7K | -37% | -$127.4K |
| D | 2022-11-17 | 2022-11-15 | TMCI | Owens Daniel E. | CHRO | M - OptEx | $0.00 | -6,250 | 186.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-15 | M | A | 6,250 | $7.03 | 16,950 | D | — | — | (F2) Includes 6,700 RSUs. |
| 2 | Common | Common Stock | 2022-11-15 | S | D | 6,250 | $20.38 | 10,700 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.3432 to $20.4338 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Includes 6,700 RSUs. |
| 3 | Derivative | Stock Option Right to Buy | 2022-11-15 | M | D | 6,250 | $0.00 | 186,375 | D | $7.03 · — to 2031-02-02 | 6,250 Common Stock | (F4) The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025. |